Monitor upcoming quarterly filings for initial LYTENAVA sales volumes and revenue contribution to gauge commercial uptake against the $485/vial WAC.
Price Chart
Executive Summary
Outlook Therapeutics announced the U.S. wholesale acquisition cost (WAC) for LYTENAVA at $485 per vial on September 16, 2026. This is a routine pricing disclosure for its newly approved product. No financial performance, revenue, or earnings data are provided; no market consensus or pricing guidance is disclosed.
Key Facts
- Outlook Therapeutics established the wholesale acquisition cost for LYTENAVA in the United States at $485 per vial.
- The filing is an Item 8.01 Other Events disclosure with no financial statements, guidance, or material agreements.
Financial Impact
Wholesale acquisition cost set at $485 per vial for LYTENAVA; no revenue, unit volume, or market size figures provided.
Risk Factors
- No information on payer reimbursement or insurance coverage for LYTENAVA is disclosed.
- No guidance on expected launch timeline or peak sales estimates are provided.
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001104659-26-108952 |
| Document: 0001104659-26-108952-index-headers.html | 0001104659-26-108952 |
| Document: 0001104659-26-108952-index.html | 0001104659-26-108952 |
| Document: 0001104659-26-108952.txt | 0001104659-26-108952 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 13, 2026 14d ago | SC 13G | $0.5638 $0.5200 | ▼ −7.77% | ▼ −6.62% | $0.5300 (−6.00%) |
Oct 6, 2026 21d ago | Press Release | $0.5720 $0.5638 | ▼ −1.43% | ▼ −1.29% | $0.5300 (−7.34%) |
Sep 18, 2026 5w ago | 8-K | $0.6863 $0.6211 | ▼ −9.50% | ▼ −8.48% | $0.5300 (−22.77%) |
Aug 14, 2026 10w ago | 8-K | $0.7564 $0.6472 | ▲ +14.44% | ▲ +13.07% | $0.5300 (+29.93%) |
Aug 14, 2026 10w ago | 424B5 | $0.7564 $0.6472 | ▲ +14.44% | ▲ +13.07% | $0.5300 (+29.93%) |
Aug 14, 2026 10w ago | 8-K | $0.7564 $0.6472 | ▲ +14.44% | ▲ +13.07% | $0.5300 (+29.93%) |
Aug 14, 2026 10w ago | Press Release | $0.7564 $0.6472 | ▼ −14.44% | ▼ −13.07% | $0.5300 (−29.93%) |
Aug 12, 2026 10w ago | Press Release | $0.8888 $0.6763 | ▲ +23.91% | ▲ +21.94% | $0.5300 (+40.37%) |
Aug 12, 2026 10w ago | 8-K | $0.8888 $0.6763 | ▲ +23.91% | ▲ +21.94% | $0.5300 (+40.37%) |
Jul 24, 2026 13w ago | 8-K | $1.07 $0.9766 | ▼ −8.30% | ▼ −9.37% | $0.5300 (−50.23%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers